TRPM8 Activators for Peripheral Neuropathy
Key facts
- Who runs it
- SHIANG-SUO HUANG
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 2
- People taking part
- 60 people enrolled
- Started
- 3 Nov 2025
- Ended
- 1 Jun 2026
- Type of study
- Interventional
- Treatments tested
- Hand and Foot Mask
- Record updated
- 15 May 2026
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patients aged 20 years or older who are currently receiving or have previously received chemotherapy and have clinical features of chemotherapy-induced peripheral neuropathy (CIPN)
- Diabetic patients aged 20 years or older who have clinical features of diabetic peripheral neuropathy (DPN)
- Patients who meet criteria 1 or 2, are willing to participate, and are able to sign an informed consent form
Who cannot take part
- Peripheral vascular disease
- Depression, history of surgery on the hands, feet, or back
- Skin conditions such as leprosy and connective tissue disorders, familial neuropathy
- Individuals with allergic symptoms
- Individuals with a history of convulsions
- Poorly controlled diabetes (HbA1c > 8%)
- Chronic kidney disease (eGFR < 30 ml/min/m²)
- Pregnant or breastfeeding women
- Individuals with G6PD deficiency (favism)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this pilot prospective cohort study is to evaluate the efficacy of a novel hand and foot mask in alleviating symptoms of peripheral neuropathy caused by chemotherapy or diabetes. The study aims to determine whether regular use of these masks can improve patient comfort and quality of life.
Read full original descriptionShow less
The primary questions this study aims to answer are:
Does the use of the hand and foot mask reduce the severity of symptoms associated with chemotherapy-induced peripheral neuropathy (CIPN) or diabetic peripheral neuropathy (DPN)?
Does the application of the masks improve patient quality of life and treatment compliance for those undergoing chemotherapy?
Participants will:
Complete an initial assessment questionnaire on Day 1.
Apply hand and foot masks daily for 5 minutes, for 7 consecutive days.
Complete a follow-up questionnaire on Day 7 to assess the effects of one week of use.
Inclusion Criteria
Individuals are eligible for the study if they meet the following criteria:
Chemotherapy-Induced Peripheral Neuropathy (CIPN) group:
Age 20 or older.
Currently receiving or having previously received chemotherapy.
Demonstrating clinical signs and symptoms of chemotherapy-induced peripheral neuropathy.
Diabetic Peripheral Neuropathy (DPN) group:
Age 20 or older.
Diagnosed with diabetes mellitus.
Demonstrating clinical signs and symptoms of diabetic peripheral neuropathy.
General requirement:
Participants must be willing to participate and capable of signing the Informed Consent Form (ICF).
The group in the trial
- treatmentTreatment being tested
Treatment: Hand and Foot Mask
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Innovative TRPM8 Activators Membrane-Based Delivery System on Peripheral Neuropathy
- Record updated
- 15 May 2026